Trial intelligence / Profile preview

EVOLVE-HF: CRT and MitraClip in Heart Failure

NCT02985268Withdrawn

Sponsor
Montréal Heart Institute
Start
Dec 2016
Primary completion
Dec 2019
01

Overview

Randomised, open-label trial (4 arms), sponsored by Montréal Heart Institute. Primary endpoint: Six-Minute Walk Test at 6 months. Planned start Dec 2016; status: withdrawn.

Beyond the preview

Go deeper on NCT02985268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02985268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call